Bevacizumab Plus Erlotinib Combination Therapy for Advanced Hereditary Leiomyomatosis and Renal Cell Carcinoma-Associated Renal Cell Carcinoma: A Multicenter Retrospective Analysis in Korean Patients
Cancer Research and Treatment - South Korea
doi 10.4143/crt.2019.086
Full Text
Open PDFAbstract
Available in full text
Date
October 15, 2019
Authors
Publisher
Korean Cancer Association